K Number
K140865
Date Cleared
2014-09-03

(153 days)

Product Code
Regulation Number
890.5500
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Infrared Heating Device, Model PM-750, temporarily increases local blood circulation where applied, and temporarily relieves minor muscle and joint aches and pains.

Device Description

The Infrared Heating Device, Model PM-750, is 110V AC powered, non-invasive, therapeutic medical device that provides continuous heat therapy through the use of infrared bulb. The device consists of a handle that houses the electronics and controls, and tungsten infrared bulb with light filter. The light filter is intended to be placed directly on the skin to provide topical heating. The infrared bulb is replaceable. The housing material is ABS.

AI/ML Overview

The provided text is a 510(k) summary for an Infrared Heating Device, Model PM-750. It details the device's characteristics and compares it to a predicate device to establish substantial equivalence, rather than presenting a standalone study with specific acceptance criteria and performance metrics for a novel AI/medical imaging device. As such, many of the requested elements (e.g., sample size for test/training sets, number of experts for ground truth, adjudication method, MRMC study, AI improvement effect size) are not applicable to this type of submission.

However, I can extract information related to performance testing that served to confirm the device's safety and effectiveness in relation to its intended use and the predicate device.

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria / ParameterReported Device Performance (PM-750)
Therapeutic Temperature Range: 40-45°CAchieves 40-45°C
Approximate Maximum Skin Temperature (Low Level): 40.5°C40.5°C
Approximate Maximum Skin Temperature (High Level): 44.5°C44.5°C
Time to reach therapeutic temperature (Low Level): 5-10 min5-10 minutes
Time to reach therapeutic temperature (High Level): 3-5 min3-5 minutes
Maintain temperature above 40°C:Maintained temperature above 40°C for at least 10-15 minutes of a 30-minute cycle time.
Maximum temperature at sensor (skin): Not exceed 45°CNever exceeded 45°C.
Safety Standards Compliance:Complies with AAMI/ANSI ES60601-1, IEC 60601-1-2.
Biocompatibility Standards Compliance:Complies with ISO 10993-1, ISO 10993-5, ISO 10993-10.

2. Sample size used for the test set and the data provenance

  • Sample Size for performance testing: 6 participants
  • Data Provenance: The document doesn't specify the country of origin for the participants, nor whether the study was retrospective or prospective. It describes an in-house performance test.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

  • This information is not applicable. The performance testing involved objective temperature measurements on participants, not expert interpretation of data for ground truth establishment.

4. Adjudication method for the test set

  • This is not applicable as the test involved objective measurements, not expert adjudication.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

  • No, a multi-reader multi-case (MRMC) comparative effectiveness study was not conducted as this device is an infrared heating device, not an AI-assisted diagnostic tool.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

  • The device itself is a standalone heating device; it does not involve algorithms or human-in-the-loop performance in the context of AI. The performance tests were conducted on the device operating independently.

7. The type of ground truth used

  • The ground truth for the performance testing was objective physical measurements: digital temperature sensor readings on the skin of participants.

8. The sample size for the training set

  • This is not applicable, as this is not an AI/machine learning device that requires a training set.

9. How the ground truth for the training set was established

  • This is not applicable, as this is not an AI/machine learning device that requires a training set.

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular pattern. Inside the circle is a stylized image of three human profiles facing right, with flowing lines representing hair or clothing.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

September 3, 2014

Pro Medical Supplies Inc. c/o Ms. Doris Dong Shanghai CV Technology Co., Ltd. Room 1706, No. 128 Songle Rd., Songjiang Area, Shanghai. China 201600

Re: K140865

Trade Name: Infrared Heating Device, Model PM-750 Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared Lamp Regulatory Class: Class II Product Code: ILY Dated: July 17, 2014 Received: July 28, 2014

Dear Ms. Dong:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

{1}------------------------------------------------

CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely vours.

Felipe Aguel -S

Carlos L. Peña, PhD, MS for Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

510(k) Number (if known) K140865

Device Name Infrared Heating Device, Model PM-750

Indications for Use (Describe)

The Infrared Heating Device, Model PM-750, temporarily increases local blood circulation where applied, and temporarily relieves minor muscle and joint aches and pains.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

× Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

)14 (19 2 -04 00

{3}------------------------------------------------

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

Section 5 510(k) Summary [As required by 21 CFR 807.92]

1. Submission Information:

510(k) Number:K140865
Date:July 15th, 2014
Type of 510(k) Submission:Traditional
Basis for 510(k) Submission:New device
Applicant/US importer:Pro Medical Supplies Inc.
1800 Byberry Rd. Unit 905, Huntingdon Valley, PA 19006, USA
Manufacturer:Shenzhen Yizekang Technologies Co., Ltd.
2nd Floor, No. 6 Factory, Hekan Road, Hekan Village,
Bantian Sub-District, Longgang District, Shenzhen 518131, China
Contactor:Doris Dong (Consultant)
Shanghai CV Technology Co., Ltd.
Room 1706, No. 128 Songle Rd., Songjiang Area, Shanghai, China 201600
E-mail: doris_d@126.com
2. Device Description:
Proprietary Name:Infrared Heating Device, Model PM-750
Common Name:Infrared lamp
Classification Name:Infrared lamp
Product Code:ILY
Device Class:2
Review Panel:Physical Medicine
Regulation Number:890.5500
Indications for use:The Infrared Heating Device, Model PM-750, temporarily increases local
blood circulation where applied, and temporarily relieves minor muscle
and joint aches and pains.
Device Description:The Infrared Heating Device, Model PM-750, is 110V AC powered,
non-invasive, therapeutic medical device that provides continuous heat
therapy through the use of infrared bulb. The device consists of a handle
that houses the electronics and controls, and tungsten infrared bulb with
light filter. The light filter is intended to be placed directly on the skin to
provide topical heating. The infrared bulb is replaceable. The housing
material is ABS.
Standards:AAMI ANSI ES60601-1, IEC 60601-1-2, ISO 10993-1, ISO 10993-5, ISO
10993-10

3. Predicate Device Identification

510k Number:K990233
Product Code:ILY
Device Name:ST-302 Infrarex
Manufacturer:Skylark Device Company Limited

4. Substantial Equivalence:

Detailed comparison data is included in Section 9 of "Substantial Equivalence Discussion" of this 510(k) submission.

A. Basic technological characteristics & Specifications, New device VS. Predicate device:

{5}------------------------------------------------

Pro Medical Supplies Inc. 1800 Byberry Rd. Unit 905, Huntingdon Valley, PA 19006, USA

ParametersNew DevicePredicate Device
1510(k) Number:K140865K990233
2Marketing clearance date:--Oct 27, 1999
3Proprietary Name:Infrared Heating Device, ModelPM-750ST-302 Infrarex
4Manufacturer:Shenzhen Yizekang Technologies Co.,Ltd.Skylark Device Company Limited
5Indications for use:The Infrared Heating Device, ModelPM-750, temporarily increases localblood circulation where applied, andtemporarily relieves minor muscle andjoint aches and pains.The Infrarex temporarily increases localblood circulation where applied, andtemporarily relieves minor muscle andjoint aches and pains.
6Power source110V AC/60Hz110V AC/60Hz
7Maximum output power7.5W7.5W
8Power switch functionHigh/Off/LowHigh/Off/Low
9Type of heat source and number1 tungsten infrared bulb1 tungsten infrared bulb
10Design PrincipleFIR (far-infrared) therapyFIR (far-infrared) therapy
11Wavelength7 000 nanometers7 000 nanometers
12Therapeutic temperature range40-45 °C40-45 °C
13Approximate maximum skintemperatureLow Level: 40.5°CHigh Level: 44.5°CLow Level: 40.5°CHigh Level: 44.5°C
14Time to reach therapeutictemperature rangeLow Level: 510 minutesHigh Level: 35 minutesLow Level: 510 minutesHigh Level: 35 minutes
15Recommended treatment timeUsed for 15-20 minutes on target areaUsed for 15-20 minutes on target area
16Weight200g200g
17Treatment area18cm²18cm²
18Performance standardsISO 10993-1, ISO 10993-5, ISO10993-10, AAMI ANSI ES60601-1,IEC 60601-1-2ISO 10993-1, ISO 10993-5, ISO10993-10, IEC 60601-1, IEC 60601-1-2

B. Substantial Equivalence Discussion

Similarities between New deviceThe new device and the predicate device are produced by different
and Predicate Device:manufacturers.
Differences between New deviceSame intended use, design, materials, technical parameters, therapeutic
and Predicate Device:parameters, and performance standards.
Conclusion: The two devices have exactly same intended use, design, materials, technical parameters,

therapeutic parameters and performance standards.

The new device is as safe and effective as the predicate device.

5. Safety and Effectiveness of the device

Testing of Infrared Heating Device, Model PM-750, includes electrical safety testing and performance testing.

The device is manufactured to comply with the following international standards:

AAMI / ANSI ES60601-1:2005/(R) 2012 And A1:2012, C1:2009/(R)2012 And A2:2010/(R)2012 (Consolidated Text) Medical Electrical Equipment - Part 1: General Requirements For Basic Safety And Essential Performance.

IEC 60601-1-2:2007, Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests The housing material and the material of the light filter of PM-750, ABS, was tested and found to meet the biocompatibility standards of:

{6}------------------------------------------------

  • ISO 10993-1:2009, Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process

  • ISO 10993-5:2009, Biological evaluation of medical devices - Part 5: Tests for In Vitro cytotoxicity, and * ISO 10993-10:2010, Biological evaluation of medical devices - Part 10: Tests for irritation and delayed-type hypersensitivity

In addition, two devices were tested for heat output, with the infrared light filter contacting the skin. Temperatures were recorded every 1 minute, up to 30 minutes, using a digital temperature sensor, through 6 participants on different body part. The test results concluded that the Infrared Heating Device, Model PM-750 was able to maintain temperature above 40℃ (the desired effective temperature) at least 10~15 minutes of the 30 minutes cycle time. The tests also showed that the temperature at the sensor (skin) never exceeded a temperature of 45℃. Both devices used for this test tracked each near 100%.

The conclusion drawn from the testing is that the device is substantially equivalent to the predicate devices.

N/A